Quantification of donor and recipient hemopoietic cells by real-time PCR of single nucleotide polymorphisms-Reference-Cited by-同舟云学术

Quantification of donor and recipient hemopoietic cells by real-time PCR of single nucleotide polymorphisms

Published:2003-03-01 Issue:3 Volume:17 Page:621-629
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Maas F,Schaap N,Kolen S,Zoetbrood A,Buño I,Dolstra H,de Witte T,Schattenberg A,van de Wiel-van Kemenade E

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2402856.pdf

Reference58 articles.

1. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555–562.

2. Butturini A, Gale RP . T-cell depletion in bone marrow transplantation for leukemia: current results and future directions. Bone Marrow Transplant 1988; 3: 185–192.

3. Gale RP, Horowitz MM, Ash RC, Champlin RE, Goldman JM, Rimm AA et al. Identical-twin bone marrow transplants for leukemia. Ann Intern Med 1994; 120: 646–652.

4. Slavin S, Nagler A, Naparstek E, Kapelushnik Y, Aker M, Cividalli G et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91: 756–763.

5. Badros A, Barlogie B, Morris C, Desikan R, Martin SR, Munshi N et al. High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions. Blood 2001; 97: 2574–2579.

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A SNP‐based genotyping strategy to detect the abuse of homologous blood transfusion from dried blood spots;Drug Testing and Analysis;2024-01-31

2. Molecular testing in the assessment of bone marrow transplant engraftment;Diagnostic Molecular Pathology;2024

3. Measurable Residual Disease Assessment in Pediatric AML;Pediatric Oncology;2024

4. Chimerism After Hematopoietic Stem Cell Transplantation;Comprehensive Hematology and Stem Cell Research;2024

5. Analysis of Subset Chimerism for MRD-Detection and Pre-Emptive Treatment in AML;Frontiers in Oncology;2022-02-17